MRMarkus Ruetz

Markus Ruetz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Markus Ruetz has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • MMUT Clinical Variants Define a Goldilocks Zone for B12-Based Radical Chemistry

    by Markus Ruetz, Benjamin Krukonis, Romila Mascarenhas, Ruma Banerjee

    MMUT is one of only two enzymes in the human proteome that depend on the B12 cofactor for activity. It catalyzes the isomerization of methylmalonyl-CoA to succinyl-CoA using 5′-deoxyadenosylcobalamin (AdoCbl) as a radical generator. Clinical mutations in MMUT are inherited in an autosomal recessive manner and are classified as B12-responsive mut– and B12 unresponsive mut0 subgroups. In this study, we report that missense mutations located at the same residue, i.e., Ala-137, are associated with distinct biochemical penalties. While the A137G mutation disables cofactor loading from the MMAB chaperone, it shows an ∼700-fold weaker affinity for binding AdoCbl from solution and exhibits an ∼700-fold lower activity than the wild-type enzyme. In contrast, the A137V variant binds AdoCbl tightly, can be partially loaded with cofactor from MMAB from solution, but exhibits ∼5000-fold lower activity, consistent with its mut0 classification. Despite the overall similarity in the crystal structure with wild-type MMUT, a close-up of the A137V active site reveals profound differences in the 5′-deoxyadenosyl moiety, which is held in a previously unseen pose. Structural analyses predict that while Gly-137 is too small to correctly position Tyr-110, critical for transition state stabilization, Val-137 is too large to even accommodate it, exemplifying the catalysis-permissive Goldilocks zone at this site. Our study predicts that the A137G variant might belong to the mut– subgroup and exhibit therapeutic responsiveness to a high dose of B12.

  • Open Access

    An unusual Co–S bond links B 12 chaperones in an interprotein complex

    by Romila Mascarenhas, Markus Ruetz, Natalie Heitman, Ryan L. Hall, Thomas C. Brunold, Ruma Banerjee

    Chaperones in trafficking pathways ensure specificity of transition metal loading and protection against adventitious side reactions. In B 12 , an essential cofactor for humans, a cobalt ion is coordinated to a >1.3 kDa tetrapyrrolic scaffold, posing logistical challenges for its translocation. In this study, we report the 3.4 Å crystal structure of the human MMACHC and MMADHC B 12 chaperones, tethered via a rarely seen covalent cobalt–sulfur bond. B 12 is bound in the base-off state to MMACHC, with Cys-261 on MMADHC serving as the upper axial ligand; the lower-axial position is vacant. The propensity of thiolato-cobalamin derivatives bound to MMACHC to undergo spontaneous decomposition via general acid catalysis or reduction/oxidation chemistry is averted in the interprotein complex with MMADHC. An exposed face in the complex suggests an exit route for B 12 . No known clinical variants localize to the interprotein interface, consistent with the cobalt–sulfur bond being key to forming the high-affinity complex.


  • A Noble Metal Substitution Leads to B12 Cofactor Mimicry by a Rhodibalamin

    by Markus Ruetz, Romila Mascarenhas, Florian Widner, Christoph Kieninger, Markos Koutmos, Bernhard Kräutler, Ruma Banerjee

    In mammals, cobalamin is an essential cofactor that is delivered by a multitude of chaperones in an elaborate trafficking pathway to two client enzymes, methionine synthase and methylmalonyl-CoA mutase (MMUT). Rhodibalamins, the rhodium analogs of cobalamins, have been described as antimetabolites due to their ability to inhibit bacterial growth. In this study, we have examined the reactivity of adenosylrhodibalamin (AdoRhbl) with two key human chaperones, MMACHC (also known as CblC) and adenosyltransferase (MMAB, also known as ATR), and with the human and Mycobacterium tuberculosis MMUT. We demonstrate that while AdoRhbl binds tightly to all four proteins, the Rh-carbon bond is resistant to homolytic (on MMAB and MMUT) as well as heterolytic (on MMACHC) rupture. On the other hand, MMAB catalyzes Rh-carbon bond formation, converting rhodi(I)balamin in the presence of ATP to AdoRhbl. We report the first crystal structure of a rhodibalamin (AdoRhbl) bound to a B12 protein, i.e., MMAB, in the presence of triphosphate, which shows a weakened but intact Rh-carbon bond. The structure provides insights into how MMAB cleaves the corresponding Co-carbon bond in a sacrificial homolytic reaction that purportedly functions as a cofactor sequestration strategy. Collectively, the study demonstrates that while the noble metal substitution of cobalt by rhodium sets up structural mimicry, it compromises chemistry, which could be exploited for targeting human and bacterial B12 chaperones and enzymes.


  • Open Access

    Bivalent molecular mimicry by ADP protects metal redox state and promotes coenzyme B 12 repair

    by Harsha Gouda, Romila Mascarenhas, Markus Ruetz, Madeline Yaw, Ruma Banerjee

    Control over transition metal redox state is essential for metalloprotein function and can be achieved via coordination chemistry and/or sequestration from bulk solvent. Human methylmalonyl-Coenzyme A (CoA) mutase (MCM) catalyzes the isomerization of methylmalonyl-CoA to succinyl-CoA using 5′-deoxyadenosylcobalamin (AdoCbl) as a metallocofactor. During catalysis, the occasional escape of the 5′-deoxyadenosine (dAdo) moiety leaves the cob(II)alamin intermediate stranded and prone to hyperoxidation to hydroxocobalamin, which is recalcitrant to repair. In this study, we have identified the use of bivalent molecular mimicry by ADP, coopting the 5′-deoxyadenosine and diphosphate moieties in the cofactor and substrate, respectively, to protect against cob(II)alamin overoxidation on MCM. Crystallographic and electron paramagnetic resonance (EPR) data reveal that ADP exerts control over the metal oxidation state by inducing a conformational change that seals off solvent access, rather than by switching five-coordinate cob(II)alamin to the more air stable four-coordinate state. Subsequent binding of methylmalonyl-CoA (or CoA) promotes cob(II)alamin off-loading from MCM to adenosyltransferase for repair. This study identifies an unconventional strategy for controlling metal redox state by an abundant metabolite to plug active site access, which is key to preserving and recycling a rare, but essential, metal cofactor.


  • Mobile loop dynamics in adenosyltransferase control binding and reactivity of coenzyme B 12

    by Romila Mascarenhas, Markus Ruetz, Liam McDevitt, Markos Koutmos, Ruma Banerjee

    Significance: Coenzyme B 12 (or 5′-deoxyadenosylcobalamin [AdoCbl]) is a cofactor for methylmalonyl-CoA mutase (MCM), which is important for propionate metabolism in Mycobacterium tuberculosis and for anaplerosis in humans. AdoCbl is synthesized by adenosyltransferase (ATR), which doubles as an escort, delivering the cofactor to MCM. The mechanism by which this large cofactor is translocated from ATR to MCM is not known. Our crystal structures of M. tuberculosis ATR reveal that mobile loops dynamically create a customized pocket to control cofactor coordination and conformation, regulating its reactivity and transportability. These changes also control solvent exposure and signaling to MCM when ATR is ready to transfer cargo, in a process where the cofactor tail plays an important role in the handover between proteins.


  • Open Access

    The human B12 trafficking protein CblC processes nitrocobalamin

    by Romila Mascarenhas, Zhu Li, Carmen Gherasim, Markus Ruetz, Ruma Banerjee


  • Itaconyl-CoA forms a stable biradical in methylmalonyl-CoA mutase and derails its activity and repair

    by Markus Ruetz, Gregory C. Campanello, Meredith Purchal, Hongying Shen, Liam McDevitt, Harsha Gouda, Shoko Wakabayashi, Junhao Zhu, Eric J. Rubin, Kurt Warncke, et al.

    Itaconate brings metalloenzyme to a halt: Controlled radicals enable unusual enzymatic transformations, but radical generation and management require dedicated systems. Ruetz et al. investigated how the immunometabolite itaconate might undermine these intricate systems to inhibit propionate metabolism, a crucial metabolic pathway in pathogenic Mycobacterium tuberculosis (Mtb) (see the Perspective by Boal). They found that the coenzyme A (CoA) derivative of itaconate can irreversibly inhibit the enzyme methylmalonyl-CoA mutase (MCM), which uses the radical-generating cofactor adenosylcobalamin, or coenzyme B 12 . Itaconyl-CoA derails the normal radical reaction catalyzed by MCM, forming a long-lived, biradical species, which is incapable of completing the catalytic cycle and cannot be recycled by the endogenous coenzyme B 12 regeneration machinery. Itaconate blocks Mtb growth on propionate, and this inhibition mechanism may be relevant to how macrophages resist Mtb infection. Science , this issue p. 589 ; see also p. 574